Business Overview
  Our Products
  R & D
  Production Facility

 

Extensive Distrubution Network

 

 

 
 
 
BUSINESS OVERVIEW

Our Products

Our pharmaceutical products comprise cardiocerebral vascular (CV) drugs, which are our main products, and non-CV drugs. We market and sell 13 CV drugs and 18 non-CV drugs. We also have over 50 products under development.

Product

Chemical Name

Used for the treatment of

Kelinao

Cinepazide Maleate Injection (80mg)

Cerebral arteriosclerosis, transient cerebral ischemic attack, cerebral thrombosis, cerebral embolism, cerebral haemorrhage residual, coronary artery disease, angina and heart infarction, as well as peripheral blood vessels diseases such as lower limb atherosclerosis, thromboarteritis obliterans and arteritis

Chuanqing

Ligustrazine Hydrochloride for Injection

Ischemia cardiocerebral vascular diseases eg cerebral thrombosis, cerebral embolism, coronary artery disease and vasculities

Saimeiao

Buflomedil Hydrochloride for Injection

Peripheral blood vessels diseases eg Raynaud Syndrome, thromboarteritis obliterans and chronic insufficient blood supply to cerebral blood vessels

Feidiao

Naloxone Hydrochloride Injection (1ml:0.4mg)

Emergency treatment of respiratory depression and unconsciousness caused by overdose of opioid drugs and alcohol

Pudiao

Naloxone Hydrochloride Injection (1ml:1.0mg)  
Quxinao Naloxone Hydrochloride Injection (2ml:2.0mg)  

Xingmai

Gingko Dispersible Tablets

Thoracic obstruction, cardialgia, stroke, hemiparalysis, coronary artery disease, angina pectoris and cerebral infarction



Some of our Non-cardiocerebral Vascular Drugs


Product

Chemical Name

Used for the treatment of

Leixingao


Ambroxol Hydrochloride and Glucose Injection


Acute/chronic respiratory diseases, and prevention of postoperative bellows complications

Kaqixiao


Pacilitaxel Injection


Various kinds of cancers, especially ovarian, breast and non-small cell lung cancers.



Some of our New Drugs Under Development


R&D drugs not previously sold within the PRC nor overseas*

Name

For treatment of

Patents Filed In

New Isoflavone Ramification


Coronary heart disease, angina, myocardial infarction, ischemic cerebrovascular disease and diabetes complications

Europe
PRC
United States

JY


Hypertension

Europe
Japan
Korea
PRC
United States

Bilobalide B for Injection


Cerebral thrombosis, coronary artery disease, angina and heart infarction

PRC

Solomanseal Rhizome Capsules


Hyperlipemia, coronary artery diseases, atherosclerosis and diabetes mellitus

PRC (Registered)



R&D drugs sold overseas but not yet approved for sale in the PRC


Name

For treatment of

Nalmefene Hydrochloride Injection


Recovery from after effects of anesthesia, treatment of respiratory depression caused by overdose of opioid drugs, and heart failure, shock and alcoholism

Naloxone Hydrochloride Nasal Spray (Nasal spray version of Naloxone Hydrochloride Injection)


Emergency treatment of respiratory depression and unconsciousness caused by overdose of opioid drugs and alcohol

Hypertonic Sodium Chloride Dextran Injection


Restore blood volume in situations such as blood loss, trauma, fire burn and shock, and prevention of blood clot

Levosulpiride Injection


Gastrointestinal functional disorder and prevention of vomiting

Roxatidine Acetate Hydrochloride for Injection

Digestive diseases, upper gastrointestinal bleeding, oesophagus inflammation

* Based on the Directors' best knowledge

 


Sihuan © 2007